Fresenius SE & Co KGaA FSNUF

Morningstar Rating
$37.35 +0.27 (0.72%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FSNUF is trading at a 469% premium.
Price
$37.45
Fair Value
$46.14
Uncertainty
High
1-Star Price
$83.38
5-Star Price
$93.16
Economic Moat
Lrbwskf
Capital Allocation

News

Trading Information

Previous Close Price
$37.08
Day Range
$37.3537.35
52-Week Range
$25.7737.35
Bid/Ask
$35.02 / $40.50
Market Cap
$21.04 Bil
Volume/Avg
100 / 1,194

Key Statistics

Price/Earnings (Normalized)
6.49
Price/Sales
0.88
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Large Core
Total Number of Employees
175,771

Competitors

Valuation

Metric
FSNUF
BAX
DVA
Price/Earnings (Normalized)
6.4912.4516.42
Price/Book Value
1.032.4021.39
Price/Sales
0.881.221.16
Price/Cash Flow
26.8611.997.08
Price/Earnings
FSNUF
BAX
DVA

Financial Strength

Metric
FSNUF
BAX
DVA
Quick Ratio
0.700.771.06
Current Ratio
1.291.401.16
Interest Coverage
2.720.634.60
Quick Ratio
FSNUF
BAX
DVA

Profitability

Metric
FSNUF
BAX
DVA
Return on Assets (Normalized)
2.86%5.24%7.26%
Return on Equity (Normalized)
8.35%19.49%128.03%
Return on Invested Capital (Normalized)
4.82%7.74%11.03%
Return on Assets
FSNUF
BAX
DVA

Medical Care Facilities Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA Healthcare Inc
HCA
JrndbympMgwfvs$104.2 Bil
Fresenius SE & Co KGaA ADR
FSNUY
Dkcqm$21.5 Bil
Tenet Healthcare Corp
THC
KzmkfyzgHzwyy$15.5 Bil
Universal Health Services Inc Class B
UHS
Yghqlk$14.9 Bil
Bangkok Dusit Medical Services PCL ADR
BDUUY
Vsg$14.8 Bil
Bangkok Dusit Medical Services PCL Shs Foreign Registered
BDULF
Grzt$14.8 Bil
DaVita Inc
DVA
WdtprphgMhfsfd$13.3 Bil
Fresenius Medical Care AG
FMCQF
Jybbnp$12.5 Bil
Fresenius Medical Care AG ADR
FMS
NktCdjcp$12.5 Bil

Sponsor Center